Latest Period
Q4 2025
Security Snapshot
GoodRx Holdings, Inc. - Common Stock (GDRX) Institutional Ownership
CUSIP: 38246G108
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
179
Shares (Excl. Options)
122,637,580
Price
$2.71
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- GDRX on Nasdaq
- Shares outstanding
- 98,685,316
- Price per share
- $2.14
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 122,637,580
- Total reported value
- $332,344,558
- % of total 13F portfolios
- 0%
- Share change
- +4,520,661
- Value change
- +$7,806,131
- Number of holders
- 179
- Price from insider filings
- $2.14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- GDRX - GoodRx Holdings, Inc. - Common Stock is tracked under CUSIP 38246G108.
- 179 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 179 to 75 between Q4 2025 and Q1 2026.
- Reported value moved from $332,344,558 to $47,922,817.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 179 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 38246G108?
CUSIP 38246G108 identifies GDRX - GoodRx Holdings, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 38246G108:
Significant Owners of GoodRx Holdings, Inc. - Common Stock (GDRX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FRANCISCO PARTNERS IV, L.P. | 36% | $288,375,283 | 60,078,184 | Francisco Partners GP IV, L.P. | 16 Mar 2025 | |||
| Idea Men, LLC | 29% | -10% | $207,188,021 | -$33,600,000 | 43,164,171 | -14% | Idea Men, LLC | 21 Mar 2025 |
| Bezdek Trevor | 5.2% | $25,881,571 | 5,391,994 | Trevor Bezdek | 16 Dec 2024 | |||
| Hirsch Douglas Joseph | 5.2% | $25,881,571 | 5,391,994 | Douglas Joseph Hirsch | 16 Dec 2024 | |||
| AMERIPRISE FINANCIAL INC | 4.3% | $22,246,901 | 4,634,771 | Ameriprise Financial, Inc. | 31 Mar 2025 | |||
| MILLENNIUM MANAGEMENT LLC | 2.1% | $10,496,971 | 2,186,869 | Millennium Management LLC | 31 Dec 2024 |
As of 31 Dec 2025, 179 institutional investors reported holding 122,637,580 shares of GoodRx Holdings, Inc. - Common Stock (GDRX). This represents 124% of the company’s total 98,685,316 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of GoodRx Holdings, Inc. - Common Stock (GDRX) together control 110% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Francisco Partners Management, LP | 61% | 60,078,184 | 0% | 35% | $162,811,879 |
| VANGUARD GROUP INC | 9.7% | 9,584,183 | +4.1% | 0% | $25,973,136 |
| Silver Lake Group, L.L.C. | 3.6% | 3,532,276 | 0% | 0.19% | $9,572,468 |
| AMERIPRISE FINANCIAL INC | 3.3% | 3,272,431 | -16% | 0% | $8,868,285 |
| RENAISSANCE TECHNOLOGIES LLC | 3.3% | 3,210,938 | -7.4% | 0.01% | $8,701,642 |
| Petrus Trust Company, LTA | 3.1% | 3,098,559 | 0% | 0.85% | $8,397,095 |
| LSV ASSET MANAGEMENT | 2.9% | 2,825,900 | +20% | 0.02% | $7,658,000 |
| DIMENSIONAL FUND ADVISORS LP | 2.7% | 2,650,452 | +6.1% | 0% | $7,182,626 |
| BlackRock, Inc. | 2% | 1,980,551 | +0.45% | 0% | $5,367,294 |
| Prescott Group Capital Management, L.L.C. | 1.8% | 1,775,502 | 0.45% | $4,811,610 | |
| Technology Crossover Management X, Ltd. | 1.7% | 1,653,566 | 0% | 0.45% | $4,481,164 |
| MILLENNIUM MANAGEMENT LLC | 1.7% | 1,636,270 | 0% | $4,434,292 | |
| GOLDMAN SACHS GROUP INC | 1.6% | 1,579,274 | +24% | 0% | $4,279,832 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.4% | 1,397,551 | -12% | 0.01% | $3,787,363 |
| AQR CAPITAL MANAGEMENT LLC | 1.2% | 1,158,546 | +188% | 0% | $3,139,660 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 1,135,563 | +22% | 0% | $3,078,230 |
| MORGAN STANLEY | 1.1% | 1,118,426 | +187% | 0% | $3,030,935 |
| Rip Road Capital Partners LP | 1.1% | 1,055,807 | -34% | 4.6% | $2,861,237 |
| STATE STREET CORP | 0.99% | 976,773 | -33% | 0% | $2,647,055 |
| MOORE CAPITAL MANAGEMENT, LP | 0.95% | 938,564 | +79% | 0.05% | $2,543,508 |
| Pacer Advisors, Inc. | 0.82% | 808,924 | -7.2% | 0.01% | $2,192,184 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 0.74% | 734,016 | +2.3% | 0% | $1,989,184 |
| UBS Group AG | 0.68% | 667,447 | +65% | 0% | $1,808,781 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0.67% | 660,133 | 0.02% | $1,788,960 | |
| STIFEL FINANCIAL CORP | 0.61% | 602,880 | -16% | 0% | $1,633,815 |
Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 24,444,941 | $47,922,817 | +$500,207 | $1.96 | 75 |
| 2025 Q4 | 122,637,580 | $332,344,558 | +$7,806,131 | $2.71 | 179 |
| 2025 Q3 | 117,322,489 | $496,241,979 | -$16,421,197 | $4.23 | 157 |
| 2025 Q2 | 120,458,255 | $599,884,035 | -$4,664,396 | $4.98 | 176 |
| 2025 Q1 | 121,628,630 | $536,393,039 | -$65,698,797 | $4.41 | 164 |
| 2024 Q4 | 135,968,354 | $632,244,381 | -$55,086,685 | $4.65 | 164 |
| 2024 Q3 | 142,032,675 | $985,856,098 | +$68,387,395 | $6.94 | 163 |
| 2024 Q2 | 131,725,500 | $1,027,464,544 | +$24,275,288 | $7.80 | 161 |
| 2024 Q1 | 128,743,736 | $913,896,618 | -$90,749,328 | $7.10 | 154 |
| 2023 Q4 | 141,637,249 | $948,962,237 | +$31,081,244 | $6.70 | 138 |
| 2023 Q3 | 137,728,416 | $775,404,583 | +$22,462,538 | $5.63 | 151 |
| 2023 Q2 | 133,773,340 | $738,443,895 | -$18,174,990 | $5.52 | 142 |
| 2023 Q1 | 136,443,326 | $852,764,205 | +$5,540,468 | $6.25 | 151 |
| 2022 Q4 | 135,872,173 | $633,174,025 | -$16,390,175 | $4.66 | 153 |
| 2022 Q3 | 139,523,504 | $651,663,220 | -$76,552,465 | $4.67 | 156 |
| 2022 Q2 | 154,602,951 | $915,568,088 | -$34,966,903 | $5.92 | 152 |
| 2022 Q1 | 145,985,292 | $2,821,832,723 | -$467,032,693 | $19.33 | 158 |
| 2021 Q4 | 152,652,179 | $4,988,313,146 | +$336,547,280 | $32.68 | 203 |
| 2021 Q3 | 139,573,202 | $5,725,100,634 | -$84,091,429 | $41.02 | 208 |
| 2021 Q2 | 57,223,135 | $2,060,732,372 | +$355,935,810 | $36.01 | 190 |
| 2021 Q1 | 131,712,129 | $5,139,356,421 | +$168,916,078 | $39.02 | 196 |
| 2020 Q4 | 127,079,191 | $5,131,253,891 | +$41,105,714 | $40.34 | 184 |
| 2020 Q3 | 36,851,110 | $2,049,308,578 | +$2,048,509,583 | $55.60 | 144 |
| 2020 Q2 | 2,367 | $85,000 | $35.91 | 1 | |
| 2020 Q1 | 2,367 | $85,000 | $35.91 | 1 | |
| 2019 Q4 | 2,367 | $85,000 | $35.91 | 1 | |
| 2019 Q3 | 2,367 | $85,000 | $35.91 | 1 | |
| 2019 Q2 | 2,367 | $85,000 | $35.91 | 1 | |
| 2019 Q1 | 2,367 | $85,000 | $35.91 | 1 |